Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.895
-0.095 (-1.90%)
Jul 23, 2026, 10:50 AM EDT - Market open
IMDX Market Cap
IMDX has a market cap or net worth of $158.06 million as of July 23, 2026. Its market cap has increased by 94.66% in one year.
Market Cap
158.06M
Enterprise Value
136.00M
1-Year Change
94.66%
Ranking
Category
Stock Price
$4.90
ChartMarket Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $158.06M, a decrease of -30.89%. That is a compound annual growth rate of -3.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 158.06M | -26.48% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 891.01M |
| Castle Biosciences | 752.49M |
| Fulgent Genetics | 554.66M |
| Myriad Genetics | 534.58M |
| Biodesix | 221.51M |
| Exagen | 119.35M |
| Burning Rock Biotech | 96.39M |
| Precipio | 41.97M |